BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38579540)

  • 1. Bronchial arterial chemoembolization with Drug-Eluting beads plus sequential chemotherapy for the treatment of stage III and IV lung squamous cell carcinoma.
    Lai L; Xu F; Zhang D; Chen J; Ying X; Chen L; Wu J; Song J; Li W; Ji J; Tu J
    Eur J Radiol; 2024 Jun; 175():111398. PubMed ID: 38579540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of drug-eluting beads bronchial arterial chemoembolization loaded with gemcitabine for treatment of non-small cell lung cancer.
    Bie Z; Li Y; Li B; Wang D; Li L; Li X
    Thorac Cancer; 2019 Sep; 10(9):1770-1778. PubMed ID: 31321919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchial artery chemoembolization with drug-eluting beads versus bronchial artery infusion followed by polyvinyl alcohol particles embolization for advanced squamous cell lung cancer: A retrospective study.
    He G; Yang K; Zhang X; Pan J; Han A; Gao Z; Li Y; Wang W
    Eur J Radiol; 2023 Apr; 161():110747. PubMed ID: 36821958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting beads bronchial arterial chemoembolization/bronchial arterial infusion chemotherapy with and without PD-1 blockade for advanced non-small cell lung cancer: a comparative single-center cohort study.
    Xu S; Li YM; Bie ZX; Li XG
    Quant Imaging Med Surg; 2023 Sep; 13(9):6241-6256. PubMed ID: 37711815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting bead bronchial arterial chemoembolization vs. chemotherapy in treating advanced non-small cell lung cancer: comparison of treatment efficacy, safety and quality of life.
    Liu XF; Lin H; Wang Q; Mu M; Pan P; Tian FF; Zhang R; Zhao WG; Bao PT
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2554-2566. PubMed ID: 33829442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
    Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA;
    Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical study.
    Zhang J; Pan Y; Shi Q; Zhang G; Jiang L; Dong X; Gu K; Wang H; Zhang X; Yang N; Li Y; Xiong J; Yi T; Peng M; Song Y; Fan Y; Cui J; Chen G; Tan W; Zang A; Guo Q; Zhao G; Wang Z; He J; Yao W; Wu X; Chen K; Hu X; Hu C; Yue L; Jiang D; Wang G; Liu J; Yu G; Li J; Bai J; Xie W; Zhao W; Wu L; Zhou C
    Cancer Commun (Lond); 2022 Jan; 42(1):3-16. PubMed ID: 34699693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma].
    Huang R; Li WH; Zhu J; Li CL; Wan HG; Chen LZ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1164-1168. PubMed ID: 32311881
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance treatment of immunotherapy after microwave ablation plus drug-eluting bead bronchial arterial chemoembolization for advanced non-small cell lung cancer: a retrospective single-center cohort study.
    Xu S; Bie ZX; Li YM; Qi J; Peng JZ; Li XG
    Quant Imaging Med Surg; 2024 May; 14(5):3473-3488. PubMed ID: 38720847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy by bronchial arterial infusion in patients with unresectable stage III squamous cell lung cancer.
    Zhu J; Zhang HP; Jiang S; Ni J
    Ther Adv Respir Dis; 2017 Aug; 11(8):301-309. PubMed ID: 28675081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting beads bronchial arterial chemoembolization vs. conventional bronchial arterial chemoembolization in the treatment of advanced non-small cell lung cancer.
    Yu G; Shen Y; Chen L; Xu X; Yang J
    Front Med (Lausanne); 2023; 10():1201468. PubMed ID: 37601792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
    Gebbia V; Galetta D; Caruso M; Verderame F; Pezzella G; Valdesi M; Borsellino N; Pandolfo G; Durini E; Rinaldi M; Loizzi M; Gebbia N; Valenza R; Tirrito ML; Varvara F; Colucci G;
    Lung Cancer; 2003 Feb; 39(2):179-89. PubMed ID: 12581571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effect of bronchial arterial infusion chemotherapy and CalliSpheres drug-eluting beads in patients with stage II-IV lung cancer: A prospective cohort study.
    Shang B; Li J; Wang X; Li D; Liang B; Wang Y; Han X; Dou W; Chen G; Shang J; Jiang S
    Thorac Cancer; 2020 Aug; 11(8):2155-2162. PubMed ID: 32603550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Eluting Bead Bronchial Arterial Chemoembolization With and Without Microwave Ablation for the Treatment of Advanced and Standard Treatment-Refractory/Ineligible Non-Small Cell Lung Cancer: A Comparative Study.
    Xu S; Bie ZX; Li YM; Li B; Kong FL; Peng JZ; Li XG
    Front Oncol; 2022; 12():851830. PubMed ID: 35371971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial.
    Wei Z; Yang X; Ye X; Feng Q; Xu Y; Zhang L; Sun W; Dong Y; Meng Q; Li T; Wang C; Li G; Zhang K; Li P; Bi J; Xue G; Sun Y; Sheng L; Liu B; Yu G; Ren H; Wang J; Sun L; Chen S; Geng D; Zhang B; Xu X; Zhang L; Sun D; Xu X; Diao C; Huang G; Li W; Han X; Wang J; Meng M; Ni Y; Zheng A; Fan W; Li Y; Li F; Fan H; Zou Z; Li Q; Tian H
    Eur Radiol; 2020 May; 30(5):2692-2702. PubMed ID: 32020400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirarubicin-loaded CalliSpheres® drug-eluting beads for the treatment of patients with stage III-IV lung cancer.
    Bi Y; Shi X; Yi M; Han X; Ren J
    Acta Radiol; 2022 Mar; 63(3):311-318. PubMed ID: 33615822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting beads bronchial arterial chemoembolization as a neoadjuvant treatment for squamous non-small cell lung cancer.
    Yu G; Hu J
    Postgrad Med; 2020 Aug; 132(6):568-571. PubMed ID: 32400251
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study.
    Park K; Cho EK; Bello M; Ahn MJ; Thongprasert S; Song EK; Soldatenkova V; Depenbrock H; Puri T; Orlando M
    Cancer Res Treat; 2017 Oct; 49(4):937-946. PubMed ID: 28111429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting beads bronchial arterial chemoembolization plus intercostals arterial infusion chemotherapy is effective and well-tolerated in treating non-small cell lung cancer patients with refractory malignant pleural effusion.
    Liu X; Lin H; Wang Q; Mu M; Pan P; Tian F; Zhang R; Zhao W; Bao P
    J Thorac Dis; 2021 Apr; 13(4):2339-2350. PubMed ID: 34012583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer.
    Paz-Ares L; Socinski MA; Shahidi J; Hozak RR; Soldatenkova V; Kurek R; Varella-Garcia M; Thatcher N; Hirsch FR
    Ann Oncol; 2016 Aug; 27(8):1573-9. PubMed ID: 27207107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.